Emerging strategies for NLRP3 inflammasome inhibition in cardio-neuroinflammatory diseases: From targeted pharmacology to precision medicine
Gene Reports · 2026-11 · 102699
DOI: 10.1016/j.genrep.2026.102699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Reports, 2026-11. Verfasst von Tawqeer Shafi und 9 weiteren Autor:innen. Die Arbeit nennt 114 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shafi, T., Pati, J. C., Rana, R., Islam, M. M., Khan, M. N., Muzaffar, K., Judder, M. I., Ghosh, I., Kapil, M. J., & Gulati, P. (2026). Emerging strategies for NLRP3 inflammasome inhibition in cardio-neuroinflammatory diseases: From targeted pharmacology to precision medicine. Gene Reports, 102699. https://doi.org/10.1016/j.genrep.2026.102699
Vancouver
Shafi T, Pati JC, Rana R, Islam MM, Khan MN, Muzaffar K, et al. Emerging strategies for NLRP3 inflammasome inhibition in cardio-neuroinflammatory diseases: From targeted pharmacology to precision medicine. Gene Reports. 2026:102699. doi:10.1016/j.genrep.2026.102699
BibTeX
@article{Shafi2026,
author = {Shafi, Tawqeer and Pati, Jagdish Chandra and Rana, Rekha and Islam, Md Moidul and Khan, M.D. Nasiruddin and Muzaffar, Khushboo and Judder, Moidul Islam and Ghosh, Ivy and Kapil, Manas Jyoti and Gulati, Puja},
title = {Emerging strategies for NLRP3 inflammasome inhibition in cardio-neuroinflammatory diseases: From targeted pharmacology to precision medicine},
journal = {Gene Reports},
year = {2026},
pages = {102699},
doi = {10.1016/j.genrep.2026.102699}
}
EUVIMED